FIELD: chemistry.
SUBSTANCE: group of inventions relates to pharmaceutical chemistry and involves a compound of formula (I) and stereoisomers thereof, a method for production thereof, a pharmaceutical composition and use thereof.
EFFECT: compound of formula (I) and stereoisomers thereof, having prolyl oligopeptidase (POP) inhibitory activity and used to treat or prevent cognitive disorder.
10 cl, 11 dwg, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1-((3S,4R)-4-(3-FLUOROPHENYL)-1-(2-METHOXYETHYL)PYRROLIDIN-3-YL)-3-(4-METHYL-3-(2-METHYLPYRIMIDIN-5-YL)-1-PHENYL-1N-PYRAZOL-5-YL)UREA AS A TRKA KINASE INHIBITOR | 2015 |
|
RU2719489C2 |
| PYRROLIDINE DERIVATIVES APPLICABLE AS CATEPSIN DERIVATIVES | 2011 |
|
RU2548684C2 |
| CATECHOL-O-METHYLTRANSFERASE INHIBITORS AND THEREOF APPLICATION FOR TREATMENT OF PSYCHOTIC DISORDERS | 2011 |
|
RU2563634C2 |
| 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2009 |
|
RU2515612C2 |
| BENZYLOXY-DERIVATIVES AS MONOAMINE OXIDASE B INHIBITORS | 2005 |
|
RU2378270C2 |
| CRYSTALLINE FORM OF 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND | 2009 |
|
RU2503662C2 |
| SYNTHESIS AND NEW SALINE FORMS OF (R)-5-((E)-2-(PYRROLIDIN-3-YLVINYL)PYRIMIDINE | 2009 |
|
RU2533819C2 |
| ALKYL [2-(2-{5-[4-(4-{2-[1-(2-METHOXYCARBONYLAMINO-ACETYL)-PYRROLIDIN-2-YL]-3H-IMIDAZOL-4-YL}-PHENYL)-BUTA-1,3-DIINYL]-1H-IMIDAZOL-2-YL}-PYRROLIDIN-1-YL)-2-OXO-ETHYL]-CARBAMATE, PHARMACEUTICAL COMPOSITION, MEDICATION, METHOD OF TREATING VIRAL DISEASES | 2013 |
|
RU2518369C1 |
| PYRROLIDINE DERIVATIVES | 2009 |
|
RU2494094C2 |
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
